Letters to the Editor Open access

Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related

Authors

Published
18 September 2023
Section
Letters to the Editor

Abstract

We thank Finsterer et al. for the attention paid to our publication; we recognize the validity of the points mentioned in their letter to the editor and will try to answer the observations made.

References

  1. Finsterer J, MohanaSundaram AS, Scorza F. Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related. Reumatismo 2023, 75:(3). doi: 10.4081/reumatismo.2023.1601. DOI: https://doi.org/10.4081/reumatismo.2023.1601
  2. Al-Rasbi S, Al-Maqbali JS, Al-Farsi R, Al Shukaili MA, Al-Riyami MH, Al Falahi Z, et al. Myocarditis, pulmonary hemorrhage, and extensive myositis with rhabdomyolysis 12 days after first dose of Pfizer-Biontech BNT162b2 mRNA covid-19 vaccine: a case report. Am J Case Rep 2022; 23: e934399. DOI: https://doi.org/10.12659/AJCR.934399
  3. Rodrigues de Carvalho M, Sá de Deus Rocha MM, Alves Bezerra V, de Pontes ME, Del Negro MC, Antunes JS, et al. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase immune-mediated necrotizing myopathy following mRNA SARS-CoV-2 vaccination. Case Rep Neurol Med 2023; 2023: 7061783 DOI: https://doi.org/10.1155/2023/7061783
  4. Syrmou V, Liaskos C, Ntavari N, Mitsimponas K, Simopoulou T, Alexiou I, et al. Covid-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report. Immunol Res 2023; 16: 1-10. DOI: https://doi.org/10.1007/s12026-023-09368-2
  5. Chang CH, Gupta R, Setyono D, Cuevas-Ocampo AK, Khoshnoodi MA. Refractory seronegative immune-mediated necrotizing myopathy after receiving mRNA-1273 SARS-CoV-2 vaccine: a case report. J Clin Neuromuscul Dis 2023; 24: 168-9. DOI: https://doi.org/10.1097/CND.0000000000000431
  6. Camargo Coronel A, Jiménez Balderas FJ, Quiñones Moya H, Hernández Zavala MR, Mandinabeitia Rodríguez P, Ramiro Hernández J, et al. Dermatomyositis post vaccine against SARS-COV2. BMC Rheumatol 2022; 6: 20. DOI: https://doi.org/10.1186/s41927-022-00250-6

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.